|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-10-23
|
|
pubmed:abstractText |
To assess the efficacy and tolerability of N-acetylcysteine (NAC) in patients with Raynaud's phenomenon (RP) secondary to systemic sclerosis (scleroderma; SSc).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2257-62
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11669166-Acetylcysteine,
pubmed-meshheading:11669166-Adult,
pubmed-meshheading:11669166-Cold Temperature,
pubmed-meshheading:11669166-Female,
pubmed-meshheading:11669166-Follow-Up Studies,
pubmed-meshheading:11669166-Free Radical Scavengers,
pubmed-meshheading:11669166-Humans,
pubmed-meshheading:11669166-Injections, Intravenous,
pubmed-meshheading:11669166-Male,
pubmed-meshheading:11669166-Middle Aged,
pubmed-meshheading:11669166-Oxidative Stress,
pubmed-meshheading:11669166-Pilot Projects,
pubmed-meshheading:11669166-Plethysmography,
pubmed-meshheading:11669166-Raynaud Disease,
pubmed-meshheading:11669166-Scleroderma, Systemic,
pubmed-meshheading:11669166-Skin Ulcer,
pubmed-meshheading:11669166-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
|
|
pubmed:affiliation |
Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, University of Ancona, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
